Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries

Bente Glintborg; Stylianos Georgiadis; Anne Gitte Loft; Asta Linauskas; Hanne Lindegaard; Oliver Hendricks; Dorte V. Jensen; Birgitte Lange Andersen; Kamilla Danebod; Anders Villumsen; Grith Eng; Charlotte Wiell; Natalia Manilo; Salome Kristensen; Johnny Raun; Jolanta Grydehøj; Stavros Chrysidis; Mette Nørgaard; Frank Mehnert; Niels Steen Krogh; Merete Lund Hetland

doi:10.1136/annrheumdis-2019-216702

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries

Bente Glintborg^*, Stylianos Georgiadis, Anne Gitte Loft, Asta Linauskas, Hanne Lindegaard, Oliver Hendricks, Dorte V. Jensen, Birgitte Lange Andersen, Kamilla Danebod, Anders Villumsen, Grith Eng, Charlotte Wiell, Natalia Manilo, Salome Kristensen, Johnny Raun, Jolanta Grydehøj, Stavros Chrysidis, Mette Nørgaard, Frank Mehnert, Niels Steen KroghMerete Lund Hetland

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	79
Udgave nummer	6
Sider (fra-til)	846-848
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2019-216702
Status	Udgivet - jun. 2020

Dokumenter og links

10.1136/annrheumdis-2019-216702

Citationsformater

Glintborg, B., Georgiadis, S., Loft, A. G., Linauskas, A., Lindegaard, H., Hendricks, O., Jensen, D. V., Andersen, B. L., Danebod, K., Villumsen, A., Eng, G., Wiell, C., Manilo, N., Kristensen, S., Raun, J., Grydehøj, J., Chrysidis, S., Nørgaard, M., Mehnert, F., ... Hetland, M. L. (2020). Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries. Annals of the Rheumatic Diseases, 79(6), 846-848. https://doi.org/10.1136/annrheumdis-2019-216702

Glintborg, Bente ; Georgiadis, Stylianos ; Loft, Anne Gitte et al. / Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : An observational nationwide study applying linkage between DANBIO and national registries. I: Annals of the Rheumatic Diseases. 2020 ; Bind 79, Nr. 6. s. 846-848.

@article{60c45b891a874c359e5cb19b5efcc80c,

title = "Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries",

keywords = "Anti-TNF, DMARDs (biologic), epidemiology, rheumatoid arthritis",

author = "Bente Glintborg and Stylianos Georgiadis and Loft, {Anne Gitte} and Asta Linauskas and Hanne Lindegaard and Oliver Hendricks and Jensen, {Dorte V.} and Andersen, {Birgitte Lange} and Kamilla Danebod and Anders Villumsen and Grith Eng and Charlotte Wiell and Natalia Manilo and Salome Kristensen and Johnny Raun and Jolanta Grydeh{\o}j and Stavros Chrysidis and Mette N{\o}rgaard and Frank Mehnert and Krogh, {Niels Steen} and Hetland, {Merete Lund}",

year = "2020",

month = jun,

doi = "10.1136/annrheumdis-2019-216702",

language = "English",

volume = "79",

pages = "846--848",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "6",

}

Glintborg, B, Georgiadis, S, Loft, AG, Linauskas, A, Lindegaard, H , Hendricks, O, Jensen, DV, Andersen, BL, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, NS & Hetland, ML 2020, 'Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries', Annals of the Rheumatic Diseases, bind 79, nr. 6, s. 846-848. https://doi.org/10.1136/annrheumdis-2019-216702

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries. / Glintborg, Bente; Georgiadis, Stylianos; Loft, Anne Gitte et al.
I: Annals of the Rheumatic Diseases, Bind 79, Nr. 6, 06.2020, s. 846-848.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4)

T2 - An observational nationwide study applying linkage between DANBIO and national registries

AU - Glintborg, Bente

AU - Georgiadis, Stylianos

AU - Loft, Anne Gitte

AU - Linauskas, Asta

AU - Lindegaard, Hanne

AU - Hendricks, Oliver

AU - Jensen, Dorte V.

AU - Andersen, Birgitte Lange

AU - Danebod, Kamilla

AU - Villumsen, Anders

AU - Eng, Grith

AU - Wiell, Charlotte

AU - Manilo, Natalia

AU - Kristensen, Salome

AU - Raun, Johnny

AU - Grydehøj, Jolanta

AU - Chrysidis, Stavros

AU - Nørgaard, Mette

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Hetland, Merete Lund

PY - 2020/6

Y1 - 2020/6

KW - Anti-TNF

KW - DMARDs (biologic)

KW - epidemiology

KW - rheumatoid arthritis

U2 - 10.1136/annrheumdis-2019-216702

DO - 10.1136/annrheumdis-2019-216702

M3 - Journal article

C2 - 32111583

AN - SCOPUS:85081994474

SN - 0003-4967

VL - 79

SP - 846

EP - 848

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -

Glintborg B, Georgiadis S, Loft AG, Linauskas A, Lindegaard H , Hendricks O et al. Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): An observational nationwide study applying linkage between DANBIO and national registries. Annals of the Rheumatic Diseases. 2020 jun.;79(6):846-848. doi: 10.1136/annrheumdis-2019-216702